» Articles » PMID: 20051634

Stem Cells in Human Neurodegenerative Disorders--time for Clinical Translation?

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2010 Jan 7
PMID 20051634
Citations 248
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cell-based approaches have received much hype as potential treatments for neurodegenerative disorders. Indeed, transplantation of stem cells or their derivatives in animal models of neurodegenerative diseases can improve function by replacing the lost neurons and glial cells and by mediating remyelination, trophic actions, and modulation of inflammation. Endogenous neural stem cells are also potential therapeutic targets because they produce neurons and glial cells in response to injury and could be affected by the degenerative process. As we discuss here, however, significant hurdles remain before these findings can be responsibly translated to novel therapies. In particular, we need to better understand the mechanisms of action of stem cells after transplantation and learn how to control stem cell proliferation, survival, migration, and differentiation in the pathological environment.

Citing Articles

Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway.

Frasca A, Miramondi F, Butti E, Indrigo M, Balbontin Arenas M, Postogna F EMBO Mol Med. 2024; 16(12):3218-3246.

PMID: 39304759 PMC: 11628625. DOI: 10.1038/s44321-024-00144-9.


Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives.

Rahimi Darehbagh R, Seyedoshohadaei S, Ramezani R, Rezaei N Eur J Med Res. 2024; 29(1):386.

PMID: 39054501 PMC: 11270957. DOI: 10.1186/s40001-024-01987-1.


Injectable Hydrogel Loaded with CDs and FTY720 Combined with Neural Stem Cells for the Treatment of Spinal Cord Injury.

Qi Z, Pan S, Yang X, Zhang R, Qin C, Yan H Int J Nanomedicine. 2024; 19:4081-4101.

PMID: 38736654 PMC: 11088866. DOI: 10.2147/IJN.S448962.


Mapping knowledge of the stem cell in traumatic brain injury: a bibliometric and visualized analysis.

Deng T, Ding R, Wang Y, Chen Y, Sun H, Zheng M Front Neurol. 2024; 15:1301277.

PMID: 38523616 PMC: 10957745. DOI: 10.3389/fneur.2024.1301277.


Intracerebellar injection of monocytic immature myeloid cells prevents the adverse effects caused by stereotactic surgery in a model of cerebellar neurodegeneration.

Del Pilar C, Garrido-Matilla L, Del Pozo-Filiu L, Lebron-Galan R, Arias R, Clemente D J Neuroinflammation. 2024; 21(1):49.

PMID: 38355633 PMC: 10867997. DOI: 10.1186/s12974-023-03000-8.


References
1.
Li B, Yamamori H, Tatebayashi Y, Shafit-Zagardo B, Tanimukai H, Chen S . Failure of neuronal maturation in Alzheimer disease dentate gyrus. J Neuropathol Exp Neurol. 2007; 67(1):78-84. PMC: 3191920. DOI: 10.1097/nen.0b013e318160c5db. View

2.
Isacson O, Bjorklund L, Schumacher J . Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Ann Neurol. 2003; 53 Suppl 3:S135-46; discussion S146-8. DOI: 10.1002/ana.10482. View

3.
Soldner F, Hockemeyer D, Beard C, Gao Q, Bell G, Cook E . Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009; 136(5):964-77. PMC: 2787236. DOI: 10.1016/j.cell.2009.02.013. View

4.
Li J, Englund E, Holton J, Soulet D, Hagell P, Lees A . Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med. 2008; 14(5):501-3. DOI: 10.1038/nm1746. View

5.
Hemming M, Patterson M, Reske-Nielsen C, Lin L, Isacson O, Selkoe D . Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med. 2007; 4(8):e262. PMC: 1952204. DOI: 10.1371/journal.pmed.0040262. View